Global Anticoagulants Market Size, Manufacturers, Opportunities and Forecast to 2030
Summary
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
According to APO Research, The global Anticoagulants market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Anticoagulants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Anticoagulants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Anticoagulants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Anticoagulants include Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson., Genentech (Roche), Boehringer Ingelheim, Lilly, Daiichi Sankyo and Otsuka, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anticoagulants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticoagulants.
The Anticoagulants market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anticoagulants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anticoagulants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anticoagulants and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anticoagulants.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Anticoagulants companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
According to APO Research, The global Anticoagulants market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Anticoagulants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Anticoagulants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Anticoagulants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Anticoagulants include Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson., Genentech (Roche), Boehringer Ingelheim, Lilly, Daiichi Sankyo and Otsuka, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anticoagulants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticoagulants.
The Anticoagulants market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anticoagulants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Sanofi
- Bristol-Myers Squibb
- Bayer
- Johnson & Johnson.
- Genentech (Roche)
- Boehringer Ingelheim
- Lilly
- Daiichi Sankyo
- Otsuka
- AstraZeneca
- Pfizer
- Aspen
- The Medicines Company
- Platelet Aggregation Inhibitors (PAI)
- Low-Molecular-Weight Heparin (LMWH)
- Direct Thrombin Inhibitor (DTI)
- Direct Factor Xa Inhibitors (DFXa)
- Vitamin K antagonists (VKA)
- Others
- VTE
- ACS/MI
- AF
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anticoagulants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anticoagulants and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anticoagulants.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Anticoagulants companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Anticoagulants Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Anticoagulants Market Size by Region (2019-2030)
1.4.1 Global Anticoagulants Market Size by Region (2019-2024)
1.4.2 Global Anticoagulants Market Size by Region (2025-2030)
1.5 Key Regions Anticoagulants Market Size (2019-2030)
1.5.1 North America Anticoagulants Market Size Growth Rate (2019-2030)
1.5.2 Europe Anticoagulants Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Anticoagulants Market Size Growth Rate (2019-2030)
1.5.4 Latin America Anticoagulants Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Anticoagulants Market Size Growth Rate (2019-2030)
2 ANTICOAGULANTS MARKET BY TYPE
2.1 Type Introduction
2.1.1 Platelet Aggregation Inhibitors (PAI)
2.1.2 Low-Molecular-Weight Heparin (LMWH)
2.1.3 Direct Thrombin Inhibitor (DTI)
2.1.4 Direct Factor Xa Inhibitors (DFXa)
2.1.5 Vitamin K antagonists (VKA)
2.1.6 Others
2.2 Global Anticoagulants Market Size by Type
2.2.1 Global Anticoagulants Market Size Overview by Type (2019-2030)
2.2.2 Global Anticoagulants Historic Market Size Review by Type (2019-2024)
2.2.3 Global Anticoagulants Market Size Forecasted by Type (2025-2030)
2.3 Global Anticoagulants Market Size by Regions
2.3.1 North America Anticoagulants Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Anticoagulants Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Anticoagulants Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Anticoagulants Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Anticoagulants Market Size Breakdown by Type (2019-2024)
3 ANTICOAGULANTS MARKET BY APPLICATION
3.1 Type Introduction
3.1.1 VTE
3.1.2 ACS/MI
3.1.3 AF
3.1.4 Others
3.2 Global Anticoagulants Market Size by Application
3.2.1 Global Anticoagulants Market Size Overview by Application (2019-2030)
3.2.2 Global Anticoagulants Historic Market Size Review by Application (2019-2024)
3.2.3 Global Anticoagulants Market Size Forecasted by Application (2025-2030)
3.3 Global Anticoagulants Market Size by Regions
3.3.1 North America Anticoagulants Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Anticoagulants Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Anticoagulants Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Anticoagulants Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Anticoagulants Market Size Breakdown by Application (2019-2024)
4 GLOBAL MARKET DYNAMICS
4.1 Anticoagulants Industry Trends
4.2 Anticoagulants Industry Drivers
4.3 Anticoagulants Industry Opportunities and Challenges
4.4 Anticoagulants Industry Restraints
5 COMPETITIVE INSIGHTS BY COMPANY
5.1 Global Top Players by Anticoagulants Revenue (2019-2024)
5.2 Global Anticoagulants Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Anticoagulants Key Company Headquarters & Area Served
5.4 Global Anticoagulants Company, Product Type & Application
5.5 Global Anticoagulants Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Anticoagulants Market CR5 and HHI
5.6.2 Global Top 5 and 10 Anticoagulants Players Market Share by Revenue in 2023
5.6.3 2023 Anticoagulants Tier 1, Tier 2, and Tier
6 COMPANY PROFILES
6.1 Sanofi
6.1.1 Sanofi Comapny Information
6.1.2 Sanofi Business Overview
6.1.3 Sanofi Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 Sanofi Anticoagulants Product Portfolio
6.1.5 Sanofi Recent Developments
6.2 Bristol-Myers Squibb
6.2.1 Bristol-Myers Squibb Comapny Information
6.2.2 Bristol-Myers Squibb Business Overview
6.2.3 Bristol-Myers Squibb Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Bristol-Myers Squibb Anticoagulants Product Portfolio
6.2.5 Bristol-Myers Squibb Recent Developments
6.3 Bayer
6.3.1 Bayer Comapny Information
6.3.2 Bayer Business Overview
6.3.3 Bayer Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Bayer Anticoagulants Product Portfolio
6.3.5 Bayer Recent Developments
6.4 Johnson & Johnson.
6.4.1 Johnson & Johnson. Comapny Information
6.4.2 Johnson & Johnson. Business Overview
6.4.3 Johnson & Johnson. Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 Johnson & Johnson. Anticoagulants Product Portfolio
6.4.5 Johnson & Johnson. Recent Developments
6.5 Genentech (Roche)
6.5.1 Genentech (Roche) Comapny Information
6.5.2 Genentech (Roche) Business Overview
6.5.3 Genentech (Roche) Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 Genentech (Roche) Anticoagulants Product Portfolio
6.5.5 Genentech (Roche) Recent Developments
6.6 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Comapny Information
6.6.2 Boehringer Ingelheim Business Overview
6.6.3 Boehringer Ingelheim Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 Boehringer Ingelheim Anticoagulants Product Portfolio
6.6.5 Boehringer Ingelheim Recent Developments
6.7 Lilly
6.7.1 Lilly Comapny Information
6.7.2 Lilly Business Overview
6.7.3 Lilly Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 Lilly Anticoagulants Product Portfolio
6.7.5 Lilly Recent Developments
6.8 Daiichi Sankyo
6.8.1 Daiichi Sankyo Comapny Information
6.8.2 Daiichi Sankyo Business Overview
6.8.3 Daiichi Sankyo Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 Daiichi Sankyo Anticoagulants Product Portfolio
6.8.5 Daiichi Sankyo Recent Developments
6.9 Otsuka
6.9.1 Otsuka Comapny Information
6.9.2 Otsuka Business Overview
6.9.3 Otsuka Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 Otsuka Anticoagulants Product Portfolio
6.9.5 Otsuka Recent Developments
6.10 AstraZeneca
6.10.1 AstraZeneca Comapny Information
6.10.2 AstraZeneca Business Overview
6.10.3 AstraZeneca Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.10.4 AstraZeneca Anticoagulants Product Portfolio
6.10.5 AstraZeneca Recent Developments
6.11 Pfizer
6.11.1 Pfizer Comapny Information
6.11.2 Pfizer Business Overview
6.11.3 Pfizer Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.11.4 Pfizer Anticoagulants Product Portfolio
6.11.5 Pfizer Recent Developments
6.12 Aspen
6.12.1 Aspen Comapny Information
6.12.2 Aspen Business Overview
6.12.3 Aspen Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.12.4 Aspen Anticoagulants Product Portfolio
6.12.5 Aspen Recent Developments
6.13 The Medicines Company
6.13.1 The Medicines Company Comapny Information
6.13.2 The Medicines Company Business Overview
6.13.3 The Medicines Company Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.13.4 The Medicines Company Anticoagulants Product Portfolio
6.13.5 The Medicines Company Recent Developments
7 NORTH AMERICA
7.1 North America Anticoagulants Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Anticoagulants Market Size by Country (2019-2024)
7.3 North America Anticoagulants Market Size Forecast by Country (2025-2030)
8 EUROPE
8.1 Europe Anticoagulants Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Anticoagulants Market Size by Country (2019-2024)
8.3 Europe Anticoagulants Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Anticoagulants Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Anticoagulants Market Size by Country (2019-2024)
9.3 Asia-Pacific Anticoagulants Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA
10.1 Latin America Anticoagulants Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Anticoagulants Market Size by Country (2019-2024)
10.3 Latin America Anticoagulants Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Anticoagulants Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Anticoagulants Market Size by Country (2019-2024)
11.3 Middle East & Africa Anticoagulants Market Size Forecast by Country (2025-2030)
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Anticoagulants Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Anticoagulants Market Size by Region (2019-2030)
1.4.1 Global Anticoagulants Market Size by Region (2019-2024)
1.4.2 Global Anticoagulants Market Size by Region (2025-2030)
1.5 Key Regions Anticoagulants Market Size (2019-2030)
1.5.1 North America Anticoagulants Market Size Growth Rate (2019-2030)
1.5.2 Europe Anticoagulants Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Anticoagulants Market Size Growth Rate (2019-2030)
1.5.4 Latin America Anticoagulants Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Anticoagulants Market Size Growth Rate (2019-2030)
2 ANTICOAGULANTS MARKET BY TYPE
2.1 Type Introduction
2.1.1 Platelet Aggregation Inhibitors (PAI)
2.1.2 Low-Molecular-Weight Heparin (LMWH)
2.1.3 Direct Thrombin Inhibitor (DTI)
2.1.4 Direct Factor Xa Inhibitors (DFXa)
2.1.5 Vitamin K antagonists (VKA)
2.1.6 Others
2.2 Global Anticoagulants Market Size by Type
2.2.1 Global Anticoagulants Market Size Overview by Type (2019-2030)
2.2.2 Global Anticoagulants Historic Market Size Review by Type (2019-2024)
2.2.3 Global Anticoagulants Market Size Forecasted by Type (2025-2030)
2.3 Global Anticoagulants Market Size by Regions
2.3.1 North America Anticoagulants Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Anticoagulants Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Anticoagulants Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Anticoagulants Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Anticoagulants Market Size Breakdown by Type (2019-2024)
3 ANTICOAGULANTS MARKET BY APPLICATION
3.1 Type Introduction
3.1.1 VTE
3.1.2 ACS/MI
3.1.3 AF
3.1.4 Others
3.2 Global Anticoagulants Market Size by Application
3.2.1 Global Anticoagulants Market Size Overview by Application (2019-2030)
3.2.2 Global Anticoagulants Historic Market Size Review by Application (2019-2024)
3.2.3 Global Anticoagulants Market Size Forecasted by Application (2025-2030)
3.3 Global Anticoagulants Market Size by Regions
3.3.1 North America Anticoagulants Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Anticoagulants Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Anticoagulants Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Anticoagulants Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Anticoagulants Market Size Breakdown by Application (2019-2024)
4 GLOBAL MARKET DYNAMICS
4.1 Anticoagulants Industry Trends
4.2 Anticoagulants Industry Drivers
4.3 Anticoagulants Industry Opportunities and Challenges
4.4 Anticoagulants Industry Restraints
5 COMPETITIVE INSIGHTS BY COMPANY
5.1 Global Top Players by Anticoagulants Revenue (2019-2024)
5.2 Global Anticoagulants Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Anticoagulants Key Company Headquarters & Area Served
5.4 Global Anticoagulants Company, Product Type & Application
5.5 Global Anticoagulants Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Anticoagulants Market CR5 and HHI
5.6.2 Global Top 5 and 10 Anticoagulants Players Market Share by Revenue in 2023
5.6.3 2023 Anticoagulants Tier 1, Tier 2, and Tier
6 COMPANY PROFILES
6.1 Sanofi
6.1.1 Sanofi Comapny Information
6.1.2 Sanofi Business Overview
6.1.3 Sanofi Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 Sanofi Anticoagulants Product Portfolio
6.1.5 Sanofi Recent Developments
6.2 Bristol-Myers Squibb
6.2.1 Bristol-Myers Squibb Comapny Information
6.2.2 Bristol-Myers Squibb Business Overview
6.2.3 Bristol-Myers Squibb Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Bristol-Myers Squibb Anticoagulants Product Portfolio
6.2.5 Bristol-Myers Squibb Recent Developments
6.3 Bayer
6.3.1 Bayer Comapny Information
6.3.2 Bayer Business Overview
6.3.3 Bayer Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Bayer Anticoagulants Product Portfolio
6.3.5 Bayer Recent Developments
6.4 Johnson & Johnson.
6.4.1 Johnson & Johnson. Comapny Information
6.4.2 Johnson & Johnson. Business Overview
6.4.3 Johnson & Johnson. Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 Johnson & Johnson. Anticoagulants Product Portfolio
6.4.5 Johnson & Johnson. Recent Developments
6.5 Genentech (Roche)
6.5.1 Genentech (Roche) Comapny Information
6.5.2 Genentech (Roche) Business Overview
6.5.3 Genentech (Roche) Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 Genentech (Roche) Anticoagulants Product Portfolio
6.5.5 Genentech (Roche) Recent Developments
6.6 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Comapny Information
6.6.2 Boehringer Ingelheim Business Overview
6.6.3 Boehringer Ingelheim Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 Boehringer Ingelheim Anticoagulants Product Portfolio
6.6.5 Boehringer Ingelheim Recent Developments
6.7 Lilly
6.7.1 Lilly Comapny Information
6.7.2 Lilly Business Overview
6.7.3 Lilly Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 Lilly Anticoagulants Product Portfolio
6.7.5 Lilly Recent Developments
6.8 Daiichi Sankyo
6.8.1 Daiichi Sankyo Comapny Information
6.8.2 Daiichi Sankyo Business Overview
6.8.3 Daiichi Sankyo Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 Daiichi Sankyo Anticoagulants Product Portfolio
6.8.5 Daiichi Sankyo Recent Developments
6.9 Otsuka
6.9.1 Otsuka Comapny Information
6.9.2 Otsuka Business Overview
6.9.3 Otsuka Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 Otsuka Anticoagulants Product Portfolio
6.9.5 Otsuka Recent Developments
6.10 AstraZeneca
6.10.1 AstraZeneca Comapny Information
6.10.2 AstraZeneca Business Overview
6.10.3 AstraZeneca Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.10.4 AstraZeneca Anticoagulants Product Portfolio
6.10.5 AstraZeneca Recent Developments
6.11 Pfizer
6.11.1 Pfizer Comapny Information
6.11.2 Pfizer Business Overview
6.11.3 Pfizer Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.11.4 Pfizer Anticoagulants Product Portfolio
6.11.5 Pfizer Recent Developments
6.12 Aspen
6.12.1 Aspen Comapny Information
6.12.2 Aspen Business Overview
6.12.3 Aspen Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.12.4 Aspen Anticoagulants Product Portfolio
6.12.5 Aspen Recent Developments
6.13 The Medicines Company
6.13.1 The Medicines Company Comapny Information
6.13.2 The Medicines Company Business Overview
6.13.3 The Medicines Company Anticoagulants Revenue, Global Share and Gross Margin (2019-2024)
6.13.4 The Medicines Company Anticoagulants Product Portfolio
6.13.5 The Medicines Company Recent Developments
7 NORTH AMERICA
7.1 North America Anticoagulants Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Anticoagulants Market Size by Country (2019-2024)
7.3 North America Anticoagulants Market Size Forecast by Country (2025-2030)
8 EUROPE
8.1 Europe Anticoagulants Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Anticoagulants Market Size by Country (2019-2024)
8.3 Europe Anticoagulants Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Anticoagulants Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Anticoagulants Market Size by Country (2019-2024)
9.3 Asia-Pacific Anticoagulants Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA
10.1 Latin America Anticoagulants Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Anticoagulants Market Size by Country (2019-2024)
10.3 Latin America Anticoagulants Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Anticoagulants Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Anticoagulants Market Size by Country (2019-2024)
11.3 Middle East & Africa Anticoagulants Market Size Forecast by Country (2025-2030)
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
LIST OF TABLES
Table 1. Global Anticoagulants Market Size (US$ Million) Comparison by Region: 2019 VS 2023 VS 2030
Table 2. Global Anticoagulants Market Size by Region (2019-2024) & (US$ Million)
Table 3. Global Anticoagulants Market Share by Region (2019-2024)
Table 4. Global Anticoagulants Market Size by Region (2025-2030) & (US$ Million)
Table 5. Global Anticoagulants Market Share by Region (2025-2030)
Table 6. Global Anticoagulants Market Size by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 7. Global Anticoagulants Market Size by Type (2019-2024) & (US$ Million)
Table 8. Global Anticoagulants Market Size Share by Type (2019-2024)
Table 9. Global Anticoagulants Market Size Forecasted by Type (2025-2030) & (US$ Million)
Table 10. Global Anticoagulants Market Size Share Forecasted by Type (2025-2030)
Table 11. North America Anticoagulants Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 12. North America Anticoagulants Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 13. Europe Anticoagulants Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 14. Europe Anticoagulants Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 15. Asia-Pacific Anticoagulants Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 16. Asia-Pacific Anticoagulants Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 17. Latin America Anticoagulants Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 18. Latin America Anticoagulants Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 19. Middle East and Africa Anticoagulants Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 20. Middle East and Africa Anticoagulants Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 21. Global Anticoagulants Market Size by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 22. Global Anticoagulants Market Size by Application (2019-2024) & (US$ Million)
Table 23. Global Anticoagulants Market Size Share by Application (2019-2024)
Table 24. Global Anticoagulants Market Size Forecasted by Application (2025-2030) & (US$ Million)
Table 25. Global Anticoagulants Market Size Share Forecasted by Application (2025-2030)
Table 26. North America Anticoagulants Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 27. North America Anticoagulants Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 28. Europe Anticoagulants Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 29. Europe Anticoagulants Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 30. Asia-Pacific Anticoagulants Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 31. Asia-Pacific Anticoagulants Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 32. Latin America Anticoagulants Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 33. Latin America Anticoagulants Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 34. Middle East and Africa Anticoagulants Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 35. Middle East and Africa Anticoagulants Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 36. Anticoagulants Industry Trends
Table 37. Anticoagulants Industry Drivers
Table 38. Anticoagulants Industry Opportunities and Challenges
Table 39. Anticoagulants Industry Restraints
Table 40. Global Anticoagulants Revenue by Company (US$ Million) & (2019-2024)
Table 41. Global Anticoagulants Revenue Market Share by Company (2019-2024)
Table 42. Global Anticoagulants Industry Company Ranking, 2022 VS 2023 VS 2024
Table 43. Global Anticoagulants Key Company Headquarters & Area Served
Table 44. Global Anticoagulants Company, Product Type & Application
Table 45. Global Anticoagulants Company Commercialization Time
Table 46. Global Company Market Concentration Ratio (CR5 and HHI)
Table 47. Global Anticoagulants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 48. Sanofi Business Overview
Table 49. Sanofi Anticoagulants Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 50. Sanofi Anticoagulants Product Portfolio
Table 51. Sanofi Recent Development
Table 52. Bristol-Myers Squibb Company Information
Table 53. Bristol-Myers Squibb Business Overview
Table 54. Bristol-Myers Squibb Anticoagulants Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 55. Bristol-Myers Squibb Anticoagulants Product Portfolio
Table 56. Bristol-Myers Squibb Recent Development
Table 57. Bayer Company Information
Table 58. Bayer Business Overview
Table 59. Bayer Anticoagulants Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 60. Bayer Anticoagulants Product Portfolio
Table 61. Bayer Recent Development
Table 62. Johnson & Johnson. Company Information
Table 63. Johnson & Johnson. Business Overview
Table 64. Johnson & Johnson. Anticoagulants Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 65. Johnson & Johnson. Anticoagulants Product Portfolio
Table 66. Johnson & Johnson. Recent Development
Table 67. Genentech (Roche) Company Information
Table 68. Genentech (Roche) Business Overview
Table 69. Genentech (Roche) Anticoagulants Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 70. Genentech (Roche) Anticoagulants Product Portfolio
Table 71. Genentech (Roche) Recent Development
Table 72. Boehringer Ingelheim Company Information
Table 73. Boehringer Ingelheim Business Overview
Table 74. Boehringer Ingelheim Anticoagulants Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 75. Boehringer Ingelheim Anticoagulants Product Portfolio
Table 76. Boehringer Ingelheim Recent Development
Table 77. Lilly Company Information
Table 78. Lilly Business Overview
Table 79. Lilly Anticoagulants Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 80. Lilly Anticoagulants Product Portfolio
Table 81. Lilly Recent Development
Table 82. Daiichi Sankyo Company Information
Table 83. Daiichi Sankyo Business Overview
Table 84. Daiichi Sankyo Anticoagulants Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 85. Daiichi Sankyo Anticoagulants Product Portfolio
Table 86. Daiichi Sankyo Recent Development
Table 87. Otsuka Company Information
Table 88. Otsuka Business Overview
Table 89. Otsuka Anticoagulants Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 90. Otsuka Anticoagulants Product Portfolio
Table 91. Otsuka Recent Development
Table 92. AstraZeneca Company Information
Table 93. AstraZeneca Business Overview
Table 94. AstraZeneca Anticoagulants Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 95. AstraZeneca Anticoagulants Product Portfolio
Table 96. AstraZeneca Recent Development
Table 97. Pfizer Company Information
Table 98. Pfizer Business Overview
Table 99. Pfizer Anticoagulants Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 100. Pfizer Anticoagulants Product Portfolio
Table 101. Pfizer Recent Development
Table 102. Aspen Company Information
Table 103. Aspen Business Overview
Table 104. Aspen Anticoagulants Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 105. Aspen Anticoagulants Product Portfolio
Table 106. Aspen Recent Development
Table 107. The Medicines Company Company Information
Table 108. The Medicines Company Business Overview
Table 109. The Medicines Company Anticoagulants Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 110. The Medicines Company Anticoagulants Product Portfolio
Table 111. The Medicines Company Recent Development
Table 112. North America Anticoagulants Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 113. North America Anticoagulants Market Size by Country (2019-2024) & (US$ Million)
Table 114. North America Anticoagulants Market Share by Country (2019-2024)
Table 115. North America Anticoagulants Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 116. North America Anticoagulants Market Share Forecast by Country (2025-2030)
Table 117. Europe Anticoagulants Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 118. Europe Anticoagulants Market Size by Country (2019-2024) & (US$ Million)
Table 119. Europe Anticoagulants Market Share by Country (2019-2024)
Table 120. Europe Anticoagulants Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 121. Europe Anticoagulants Market Share Forecast by Country (2025-2030)
Table 122. Asia-Pacific Anticoagulants Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 123. Asia-Pacific Anticoagulants Market Size by Country (2019-2024) & (US$ Million)
Table 124. Asia-Pacific Anticoagulants Market Share by Country (2019-2024)
Table 125. Asia-Pacific Anticoagulants Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 126. Asia-Pacific Anticoagulants Market Share Forecast by Country (2025-2030)
Table 127. Latin America Anticoagulants Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 128. Latin America Anticoagulants Market Size by Country (2019-2024) & (US$ Million)
Table 129. Latin America Anticoagulants Market Share by Country (2019-2024)
Table 130. Latin America Anticoagulants Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 131. Latin America Anticoagulants Market Share Forecast by Country (2025-2030)
Table 132. Middle East & Africa Anticoagulants Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 133. Middle East & Africa Anticoagulants Market Size by Country (2019-2024) & (US$ Million)
Table 134. Middle East & Africa Anticoagulants Market Share by Country (2019-2024)
Table 135. Middle East & Africa Anticoagulants Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 136. Middle East & Africa Anticoagulants Market Share Forecast by Country (2025-2030)
Table 137. Research Programs/Design for This Report
Table 138. Authors List of This Report
Table 139. Secondary Sources
Table 140. Primary Sources
Table 1. Global Anticoagulants Market Size (US$ Million) Comparison by Region: 2019 VS 2023 VS 2030
Table 2. Global Anticoagulants Market Size by Region (2019-2024) & (US$ Million)
Table 3. Global Anticoagulants Market Share by Region (2019-2024)
Table 4. Global Anticoagulants Market Size by Region (2025-2030) & (US$ Million)
Table 5. Global Anticoagulants Market Share by Region (2025-2030)
Table 6. Global Anticoagulants Market Size by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 7. Global Anticoagulants Market Size by Type (2019-2024) & (US$ Million)
Table 8. Global Anticoagulants Market Size Share by Type (2019-2024)
Table 9. Global Anticoagulants Market Size Forecasted by Type (2025-2030) & (US$ Million)
Table 10. Global Anticoagulants Market Size Share Forecasted by Type (2025-2030)
Table 11. North America Anticoagulants Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 12. North America Anticoagulants Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 13. Europe Anticoagulants Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 14. Europe Anticoagulants Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 15. Asia-Pacific Anticoagulants Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 16. Asia-Pacific Anticoagulants Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 17. Latin America Anticoagulants Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 18. Latin America Anticoagulants Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 19. Middle East and Africa Anticoagulants Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 20. Middle East and Africa Anticoagulants Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 21. Global Anticoagulants Market Size by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 22. Global Anticoagulants Market Size by Application (2019-2024) & (US$ Million)
Table 23. Global Anticoagulants Market Size Share by Application (2019-2024)
Table 24. Global Anticoagulants Market Size Forecasted by Application (2025-2030) & (US$ Million)
Table 25. Global Anticoagulants Market Size Share Forecasted by Application (2025-2030)
Table 26. North America Anticoagulants Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 27. North America Anticoagulants Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 28. Europe Anticoagulants Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 29. Europe Anticoagulants Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 30. Asia-Pacific Anticoagulants Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 31. Asia-Pacific Anticoagulants Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 32. Latin America Anticoagulants Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 33. Latin America Anticoagulants Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 34. Middle East and Africa Anticoagulants Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 35. Middle East and Africa Anticoagulants Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 36. Anticoagulants Industry Trends
Table 37. Anticoagulants Industry Drivers
Table 38. Anticoagulants Industry Opportunities and Challenges
Table 39. Anticoagulants Industry Restraints
Table 40. Global Anticoagulants Revenue by Company (US$ Million) & (2019-2024)
Table 41. Global Anticoagulants Revenue Market Share by Company (2019-2024)
Table 42. Global Anticoagulants Industry Company Ranking, 2022 VS 2023 VS 2024
Table 43. Global Anticoagulants Key Company Headquarters & Area Served
Table 44. Global Anticoagulants Company, Product Type & Application
Table 45. Global Anticoagulants Company Commercialization Time
Table 46. Global Company Market Concentration Ratio (CR5 and HHI)
Table 47. Global Anticoagulants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 48. Sanofi Business Overview
Table 49. Sanofi Anticoagulants Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 50. Sanofi Anticoagulants Product Portfolio
Table 51. Sanofi Recent Development
Table 52. Bristol-Myers Squibb Company Information
Table 53. Bristol-Myers Squibb Business Overview
Table 54. Bristol-Myers Squibb Anticoagulants Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 55. Bristol-Myers Squibb Anticoagulants Product Portfolio
Table 56. Bristol-Myers Squibb Recent Development
Table 57. Bayer Company Information
Table 58. Bayer Business Overview
Table 59. Bayer Anticoagulants Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 60. Bayer Anticoagulants Product Portfolio
Table 61. Bayer Recent Development
Table 62. Johnson & Johnson. Company Information
Table 63. Johnson & Johnson. Business Overview
Table 64. Johnson & Johnson. Anticoagulants Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 65. Johnson & Johnson. Anticoagulants Product Portfolio
Table 66. Johnson & Johnson. Recent Development
Table 67. Genentech (Roche) Company Information
Table 68. Genentech (Roche) Business Overview
Table 69. Genentech (Roche) Anticoagulants Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 70. Genentech (Roche) Anticoagulants Product Portfolio
Table 71. Genentech (Roche) Recent Development
Table 72. Boehringer Ingelheim Company Information
Table 73. Boehringer Ingelheim Business Overview
Table 74. Boehringer Ingelheim Anticoagulants Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 75. Boehringer Ingelheim Anticoagulants Product Portfolio
Table 76. Boehringer Ingelheim Recent Development
Table 77. Lilly Company Information
Table 78. Lilly Business Overview
Table 79. Lilly Anticoagulants Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 80. Lilly Anticoagulants Product Portfolio
Table 81. Lilly Recent Development
Table 82. Daiichi Sankyo Company Information
Table 83. Daiichi Sankyo Business Overview
Table 84. Daiichi Sankyo Anticoagulants Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 85. Daiichi Sankyo Anticoagulants Product Portfolio
Table 86. Daiichi Sankyo Recent Development
Table 87. Otsuka Company Information
Table 88. Otsuka Business Overview
Table 89. Otsuka Anticoagulants Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 90. Otsuka Anticoagulants Product Portfolio
Table 91. Otsuka Recent Development
Table 92. AstraZeneca Company Information
Table 93. AstraZeneca Business Overview
Table 94. AstraZeneca Anticoagulants Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 95. AstraZeneca Anticoagulants Product Portfolio
Table 96. AstraZeneca Recent Development
Table 97. Pfizer Company Information
Table 98. Pfizer Business Overview
Table 99. Pfizer Anticoagulants Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 100. Pfizer Anticoagulants Product Portfolio
Table 101. Pfizer Recent Development
Table 102. Aspen Company Information
Table 103. Aspen Business Overview
Table 104. Aspen Anticoagulants Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 105. Aspen Anticoagulants Product Portfolio
Table 106. Aspen Recent Development
Table 107. The Medicines Company Company Information
Table 108. The Medicines Company Business Overview
Table 109. The Medicines Company Anticoagulants Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 110. The Medicines Company Anticoagulants Product Portfolio
Table 111. The Medicines Company Recent Development
Table 112. North America Anticoagulants Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 113. North America Anticoagulants Market Size by Country (2019-2024) & (US$ Million)
Table 114. North America Anticoagulants Market Share by Country (2019-2024)
Table 115. North America Anticoagulants Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 116. North America Anticoagulants Market Share Forecast by Country (2025-2030)
Table 117. Europe Anticoagulants Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 118. Europe Anticoagulants Market Size by Country (2019-2024) & (US$ Million)
Table 119. Europe Anticoagulants Market Share by Country (2019-2024)
Table 120. Europe Anticoagulants Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 121. Europe Anticoagulants Market Share Forecast by Country (2025-2030)
Table 122. Asia-Pacific Anticoagulants Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 123. Asia-Pacific Anticoagulants Market Size by Country (2019-2024) & (US$ Million)
Table 124. Asia-Pacific Anticoagulants Market Share by Country (2019-2024)
Table 125. Asia-Pacific Anticoagulants Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 126. Asia-Pacific Anticoagulants Market Share Forecast by Country (2025-2030)
Table 127. Latin America Anticoagulants Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 128. Latin America Anticoagulants Market Size by Country (2019-2024) & (US$ Million)
Table 129. Latin America Anticoagulants Market Share by Country (2019-2024)
Table 130. Latin America Anticoagulants Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 131. Latin America Anticoagulants Market Share Forecast by Country (2025-2030)
Table 132. Middle East & Africa Anticoagulants Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 133. Middle East & Africa Anticoagulants Market Size by Country (2019-2024) & (US$ Million)
Table 134. Middle East & Africa Anticoagulants Market Share by Country (2019-2024)
Table 135. Middle East & Africa Anticoagulants Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 136. Middle East & Africa Anticoagulants Market Share Forecast by Country (2025-2030)
Table 137. Research Programs/Design for This Report
Table 138. Authors List of This Report
Table 139. Secondary Sources
Table 140. Primary Sources
LIST OF FIGURES
Figure 1. Anticoagulants Product Picture
Figure 2. Global Anticoagulants Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Anticoagulants Market Size (2019-2030) & (US$ Million)
Figure 4. Global Anticoagulants Market Share by Region: 2023 VS 2030
Figure 5. Global Anticoagulants Market Share by Region (2019-2030)
Figure 6. North America Anticoagulants Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 7. Europe Anticoagulants Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 8. Asia-Pacific Anticoagulants Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 9. Latin America Anticoagulants Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 10. Middle East & Africa Anticoagulants Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 11. Product Picture of Platelet Aggregation Inhibitors (PAI)
Figure 12. Global Platelet Aggregation Inhibitors (PAI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 13. Product Picture of Low-Molecular-Weight Heparin (LMWH)
Figure 14. Global Low-Molecular-Weight Heparin (LMWH) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 15. Product Picture of Direct Thrombin Inhibitor (DTI)
Figure 16. Global Direct Thrombin Inhibitor (DTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. Product Picture of Direct Factor Xa Inhibitors (DFXa)
Figure 18. Global Direct Factor Xa Inhibitors (DFXa) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Product Picture of Vitamin K antagonists (VKA)
Figure 20. Global Vitamin K antagonists (VKA) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Product Picture of Others
Figure 22. Global Others Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Global Anticoagulants Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 24. Global Anticoagulants Market Share by Type 2023 VS 2030
Figure 25. North America Anticoagulants Market Size Share by Type (2019-2030)
Figure 26. Europe Anticoagulants Market Size Share by Type (2019-2030)
Figure 27. Asia-Pacific Anticoagulants Market Size Share by Type (2019-2030)
Figure 28. Latin America Anticoagulants Market Size Share by Type (2019-2030)
Figure 29. Middle East and Africa Anticoagulants Market Size Share by Type (2019-2030)
Figure 30. Product Picture of VTE
Figure 31. Global VTE Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Product Picture of ACS/MI
Figure 33. Global ACS/MI Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Product Picture of AF
Figure 35. Global AF Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Product Picture of Others
Figure 37. Global Others Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Global Anticoagulants Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 39. Global Anticoagulants Market Share by Application 2023 VS 2030
Figure 40. North America Anticoagulants Market Size Share by Application (2019-2030)
Figure 41. Europe Anticoagulants Market Size Share by Application (2019-2030)
Figure 42. Asia-Pacific Anticoagulants Market Size Share by Application (2019-2030)
Figure 43. Latin America Anticoagulants Market Size Share by Application (2019-2030)
Figure 44. Middle East and Africa Anticoagulants Market Size Share by Application (2019-2030)
Figure 45. Global Top 5 and 10 Anticoagulants Players Market Share by Revenue in 2023
Figure 46. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 47. North America Anticoagulants Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 48. North America Anticoagulants Market Share by Country: 2019 VS 2023 VS 2030
Figure 49. North America Anticoagulants Market Share by Country (2019-2030)
Figure 50. Europe Anticoagulants Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 51. Europe Anticoagulants Market Share by Country: 2019 VS 2023 VS 2030
Figure 52. Europe Anticoagulants Market Share by Country (2019-2030)
Figure 53. Asia-Pacific Anticoagulants Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 54. Asia-Pacific Anticoagulants Market Share by Country: 2019 VS 2023 VS 2030
Figure 55. Asia-Pacific Anticoagulants Market Share by Country (2019-2030)
Figure 56. Latin America Anticoagulants Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 57. Latin America Anticoagulants Market Share by Country: 2019 VS 2023 VS 2030
Figure 58. Latin America Anticoagulants Market Share by Country (2019-2030)
Figure 59. Middle East & Africa Anticoagulants Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 60. Middle East & Africa Anticoagulants Market Share by Country: 2019 VS 2023 VS 2030
Figure 61. Middle East & Africa Anticoagulants Market Share by Country (2019-2030)
Figure 62. Years Considered
Figure 63. Research Process
Figure 64. Key Executives Interviewed
Figure 1. Anticoagulants Product Picture
Figure 2. Global Anticoagulants Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Anticoagulants Market Size (2019-2030) & (US$ Million)
Figure 4. Global Anticoagulants Market Share by Region: 2023 VS 2030
Figure 5. Global Anticoagulants Market Share by Region (2019-2030)
Figure 6. North America Anticoagulants Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 7. Europe Anticoagulants Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 8. Asia-Pacific Anticoagulants Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 9. Latin America Anticoagulants Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 10. Middle East & Africa Anticoagulants Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 11. Product Picture of Platelet Aggregation Inhibitors (PAI)
Figure 12. Global Platelet Aggregation Inhibitors (PAI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 13. Product Picture of Low-Molecular-Weight Heparin (LMWH)
Figure 14. Global Low-Molecular-Weight Heparin (LMWH) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 15. Product Picture of Direct Thrombin Inhibitor (DTI)
Figure 16. Global Direct Thrombin Inhibitor (DTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. Product Picture of Direct Factor Xa Inhibitors (DFXa)
Figure 18. Global Direct Factor Xa Inhibitors (DFXa) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Product Picture of Vitamin K antagonists (VKA)
Figure 20. Global Vitamin K antagonists (VKA) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Product Picture of Others
Figure 22. Global Others Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Global Anticoagulants Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 24. Global Anticoagulants Market Share by Type 2023 VS 2030
Figure 25. North America Anticoagulants Market Size Share by Type (2019-2030)
Figure 26. Europe Anticoagulants Market Size Share by Type (2019-2030)
Figure 27. Asia-Pacific Anticoagulants Market Size Share by Type (2019-2030)
Figure 28. Latin America Anticoagulants Market Size Share by Type (2019-2030)
Figure 29. Middle East and Africa Anticoagulants Market Size Share by Type (2019-2030)
Figure 30. Product Picture of VTE
Figure 31. Global VTE Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Product Picture of ACS/MI
Figure 33. Global ACS/MI Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Product Picture of AF
Figure 35. Global AF Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Product Picture of Others
Figure 37. Global Others Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Global Anticoagulants Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 39. Global Anticoagulants Market Share by Application 2023 VS 2030
Figure 40. North America Anticoagulants Market Size Share by Application (2019-2030)
Figure 41. Europe Anticoagulants Market Size Share by Application (2019-2030)
Figure 42. Asia-Pacific Anticoagulants Market Size Share by Application (2019-2030)
Figure 43. Latin America Anticoagulants Market Size Share by Application (2019-2030)
Figure 44. Middle East and Africa Anticoagulants Market Size Share by Application (2019-2030)
Figure 45. Global Top 5 and 10 Anticoagulants Players Market Share by Revenue in 2023
Figure 46. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 47. North America Anticoagulants Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 48. North America Anticoagulants Market Share by Country: 2019 VS 2023 VS 2030
Figure 49. North America Anticoagulants Market Share by Country (2019-2030)
Figure 50. Europe Anticoagulants Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 51. Europe Anticoagulants Market Share by Country: 2019 VS 2023 VS 2030
Figure 52. Europe Anticoagulants Market Share by Country (2019-2030)
Figure 53. Asia-Pacific Anticoagulants Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 54. Asia-Pacific Anticoagulants Market Share by Country: 2019 VS 2023 VS 2030
Figure 55. Asia-Pacific Anticoagulants Market Share by Country (2019-2030)
Figure 56. Latin America Anticoagulants Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 57. Latin America Anticoagulants Market Share by Country: 2019 VS 2023 VS 2030
Figure 58. Latin America Anticoagulants Market Share by Country (2019-2030)
Figure 59. Middle East & Africa Anticoagulants Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 60. Middle East & Africa Anticoagulants Market Share by Country: 2019 VS 2023 VS 2030
Figure 61. Middle East & Africa Anticoagulants Market Share by Country (2019-2030)
Figure 62. Years Considered
Figure 63. Research Process
Figure 64. Key Executives Interviewed
